Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy

被引:204
作者
Buytaert, Esther
Callewaert, Geert
Hendrickx, Nico
Scorrano, Luca
Hartmann, Dieter
Missiaen, Ludwig
Vandenheede, Jackie R.
Heirman, Ingeborg
Grooten, Johan
Agostinis, Patrizia
机构
[1] Catholic Univ Louvain, Dept Mol & Cell Biol, Fac Med, B-1348 Louvain, Belgium
[2] Dulbecco Telethon Inst, Venetian Inst Mol Med, Padua, Italy
[3] Univ Ghent, B-9000 Ghent, Belgium
关键词
D O I
10.1096/fj.05-4305fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Both the commitment event and the modality of cell death in photodynamic therapy (PDT) remain poorly defined. We report that PDT with endoplasmic reticulum (ER)-associating hypericin leads to an immediate loss of SERCA2 protein levels, causing disruption of Ca2+ homeostasis and cell death. Protection of SERCA2 protein rescues ER-Ca2+ levels and prevents cell death, suggesting that SERCA2 photodestruction with consequent incapability of the ER to maintain intracellular Ca2+ homeostasis is causal to cell killing. Apoptosis is rapidly initiated after ER-Ca2+ depletion and strictly requires the BAX/BAK gateway at the mitochondria. Bax(-/-)Bak(-/-) double-knockout (DKO) cells are protected from apoptosis but undergo autophagy-associated cell death as revealed by electron microscopy and biochemical analysis. Autophagy inhibitors, but not caspase antagonists, significantly reduce death of DKO cells, suggesting that sustained autophagy is lethal. Thus, following ER photodamage and consequent disruption of Ca2+ homeostasis, BAX and BAK proteins model PDT-mediated cell killing, which is executed through apoptosis in their presence or via an autophagic pathway in their absence.
引用
收藏
页码:756 / +
页数:30
相关论文
共 52 条
[1]
Regulatory pathways in photodynamic therapy induced apoptosis [J].
Agostinis, P ;
Buytaert, E ;
Breyssens, H ;
Hendrickx, N .
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES, 2004, 3 (08) :721-729
[2]
Hypericin in cancer treatment: more light on the way [J].
Agostinis, P ;
Vantieghem, A ;
Merlevede, W ;
de Witte, PAM .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2002, 34 (03) :221-241
[3]
The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin [J].
Assefa, Z ;
Vantieghem, A ;
Declercq, W ;
Vandenabeele, P ;
Vandenheede, JR ;
Merlevede, W ;
de Witte, P ;
Agostinis, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (13) :8788-8796
[4]
Calcium signalling: Dynamics, homeostasis and remodelling [J].
Berridge, MJ ;
Bootman, MD ;
Roderick, HL .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (07) :517-529
[5]
Signal transduction of thapsigargin-induced apoptosis in osteoblast [J].
Chae, HJ ;
Chae, SW ;
Weon, KH ;
Kang, JS ;
Kim, HR .
BONE, 1999, 25 (04) :453-458
[6]
Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model [J].
Chen, B ;
Roskams, T ;
Xu, Y ;
Agostinis, P ;
de Witte, PAM .
INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (02) :284-290
[7]
Recombinant aequorin and green fluorescent protein as valuable tools in the study of cell signalling [J].
Chiesa, A ;
Rapizzi, E ;
Tosello, V ;
Pinton, P ;
de Virgilio, M ;
Fogarty, KE ;
Rizzuto, R .
BIOCHEMICAL JOURNAL, 2001, 355 (01) :1-12
[8]
Bax is essential for mitochondrion-mediated apoptosis but not for cell death caused by photodynamic therapy [J].
Chiu, SM ;
Xue, LY ;
Usuda, J ;
Azizuddin, K ;
Oleinick, NL .
BRITISH JOURNAL OF CANCER, 2003, 89 (08) :1590-1597
[9]
Cell death: Critical control points [J].
Danial, NN ;
Korsmeyer, SJ .
CELL, 2004, 116 (02) :205-219
[10]
Delaey EM, 1999, INT J ONCOL, V14, P759